Stockscreener 앱 받기
0.6614
0.00%
0.00
전일 마감가:
$0.6614
열려 있는:
$0.652
하루 거래량:
220.47K
Relative Volume:
0.75
시가총액:
$22.57M
수익:
-
순이익/손실:
$-98.79M
주가수익비율:
-0.2023
EPS:
-3.27
순현금흐름:
$-51.66M
1주 성능:
+7.98%
1개월 성능:
+2.27%
6개월 성능:
+139.72%
1년 성능:
-75.68%
1일 변동 폭
$0.612
$0.6912
1주일 범위
$0.59
$0.6912
52주 변동 폭
$0.2404
$3.98
Relmada Therapeutics Inc Stock (RLMD) Company Profile
명칭
Relmada Therapeutics Inc
전화
646 876 3459
주소
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
RLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 3.03 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.59 | 1.80B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.42 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.72 | 117.56M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.48 | 337.18M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.25 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-09-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-06-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-10-14 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-14 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-11-18 | 개시 | Mizuho | Buy |
| 2021-05-20 | 재개 | Goldman | Buy |
| 2020-10-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-04 | 개시 | SunTrust | Buy |
| 2020-04-21 | 개시 | Goldman | Buy |
| 2020-01-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-16 | 개시 | Guggenheim | Buy |
모두보기
Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스
What MACD signals say about Relmada Therapeutics Inc.2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Relmada Therapeutics Inc. stock trend outlook and recovery path2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Best data tools to analyze Relmada Therapeutics Inc. stockGap Up & Fast Entry Momentum Trade Alerts - Newser
Advanced analytics toolkit walkthrough for Relmada Therapeutics Inc.July 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Statistical indicators supporting Relmada Therapeutics Inc.’s strengthTrade Performance Summary & Growth Focused Stock Pick Reports - Newser
Analyzing Relmada Therapeutics Inc. with multi timeframe chartsWeekly Gains Report & Smart Money Movement Tracker - Newser
Price momentum metrics for Relmada Therapeutics Inc. explained2025 Sector Review & Fast Moving Stock Watchlists - Newser
Market reaction to Relmada Therapeutics Inc.’s recent news2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Is a relief rally coming for Relmada Therapeutics Inc. holdersQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Chartists See Breakout Potential in Relmada Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Using AI based signals to follow Relmada Therapeutics Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - Newser
How to integrate Relmada Therapeutics Inc. into portfolio analysis toolsWeekly Trade Report & Verified Technical Trade Signals - Newser
What data driven models say about Relmada Therapeutics Inc.’s futureQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser
Should you wait for a breakout in Relmada Therapeutics Inc.July 2025 Reactions & Accurate Buy Signal Alerts - Newser
Tools to assess Relmada Therapeutics Inc.’s risk profileJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Evaluating Relmada Therapeutics Inc. with trendline analysisMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
What’s next for Relmada Therapeutics Inc. stock pricePortfolio Update Summary & Entry Point Strategy Guides - Newser
Relmada Therapeutics Inc. stock momentum explainedEarnings Risk Summary & Short-Term Trading Alerts - Newser
Is it too late to sell Relmada Therapeutics Inc.July 2025 Market Mood & High Yield Stock Recommendations - Newser
Is Relmada Therapeutics Inc.’s growth already priced inJuly 2025 Momentum & Low Drawdown Investment Ideas - sundaytimes.kr
Published on: 2025-08-23 21:25:05 - Newser
What is Relmada Therapeutics Inc. s revenue forecastWeekly Earnings Recap & Risk Managed Trade Strategies - theviewers.co.kr
Published on: 2025-08-23 18:28:07 - Newser
Is it time to cut losses on Relmada Therapeutics Inc.Trade Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
Aug Catalysts: Can Relmada Therapeutics Inc. maintain its current growth rateEarnings Risk Report & Fast Gaining Stock Strategy Reports - theviewers.co.kr
Will Relmada Therapeutics Inc. benefit from macro trendsJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Machine Learning Models Forecast Relmada Therapeutics Inc. UptickPortfolio Return Summary & Consistent Profit Trade Alerts - kangso.co.kr
Why Relmada Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru
Recovery Setup Building in Relmada Therapeutics Inc. Experts SayQuarterly Market Review & Community Shared Stock Ideas - beatles.ru
When is the best time to exit Relmada Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - Newser
Is Relmada Therapeutics Inc. a candidate for recovery playTrade Analysis Report & Reliable Entry Point Trade Alerts - Newser
Will Relmada Therapeutics Inc. price bounce be sustainable2025 Biggest Moves & Precise Buy Zone Identification - Newser
Relmada Therapeutics Inc (RLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Relmada Therapeutics Inc 주식 (RLMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shenouda Maged | Chief Financial Officer |
May 19 '25 |
Buy |
0.49 |
90,000 |
43,686 |
228,335 |
| Shenouda Maged | Chief Financial Officer |
May 20 '25 |
Buy |
0.52 |
60,000 |
31,422 |
288,335 |
| Shenouda Maged | Chief Financial Officer |
May 16 '25 |
Buy |
0.44 |
50,000 |
22,100 |
138,335 |
| Ence Chuck | CA and CO |
May 16 '25 |
Buy |
0.45 |
228,961 |
103,330 |
267,931 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 20 '25 |
Buy |
0.56 |
147,686 |
82,246 |
734,024 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 16 '25 |
Buy |
0.45 |
172,314 |
77,472 |
556,338 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 19 '25 |
Buy |
0.50 |
30,000 |
14,994 |
586,338 |
| TRAVERSA SERGIO | Chief Executive Officer |
Sep 11 '24 |
Buy |
2.99 |
51,407 |
153,707 |
384,024 |
| TRAVERSA SERGIO | Chief Executive Officer |
Sep 09 '24 |
Buy |
2.71 |
55,579 |
150,619 |
299,603 |
| TRAVERSA SERGIO | Chief Executive Officer |
Sep 10 '24 |
Buy |
2.75 |
33,014 |
90,788 |
332,617 |
0.89%
7.86%
자본화:
|
볼륨(24시간):